In addition to lower complement levels, patients with ITP had elevated CRP levels compared with healthy controls. Serum complement levels could indicate disease activity in patients with immune ...

Pulmonary rehabilitation is an underutilized tool in the management of PAH. Referrals to pulmonary rehabilitation among patients with pulmonary arterial hypertension (PAH) are relatively low despite ...

Patients with MF who did not receive ruxolitinib had higher levels of the inflammatory cytokines CD25, REG3A, IL18, and ST2 than those treated with ruxolitinib at baseline. The baseline cytokine ...

There are a few debated issues about what one is at risk for if the person has alpha-1 antitrypsin deficiency (AATD). Some things are known for sure, such as the risk of lung or liver disease and ...

Cardiovascular autonomic dysfunction was more common among patients with NMOSD than those with MS. This finding suggests that cardiovascular monitoring should be a priority in patients with NMOSD who ...

Rare Disease Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

Rare Disease Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

Extremely low baseline neutrophil count was a strong predictor of early death, underscoring the need for early risk stratification. Treatment with porcine antihuman T-lymphocyte globulin (ATG) and ...

(L-R) Rare Disease Advisor senior correspondent Larry Luxner, patient columnists Alithea Athans, Tara Keith and Tom Bartlett, and director of advocacy relations Vera Luxner (Photo by Riya Ajmera) ...

Hereditary alpha-tryptasemia may be investigated as a possible cause of significantly elevated basal serum tryptase levels. A middle-aged man who presented with anaphylaxis was concurrently diagnosed ...

The patient recovered from surgery with no respiratory complications or any exacerbation in the symptoms of CIDP. Researchers from Iran presented the case of a patient with chronic inflammatory ...

At 52 weeks, approximately 57% of participants on secukinumab treatment noted a DLQI total score of 0 or 1. Investigators conducted a multicenter, open-label, observational study in which all ...